
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc.(ANIP)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · ANIP · 截至 Jun 8, 2026
关键指标
探索 ANI Pharmaceuticals, Inc. 数据
anip stock data · financials财务快照
完整财报分析师评级与目标价
完整预测合计: 10 · 买入占比: 70.0%
根据过去 3 个月内 10 位华尔街分析师,ANIP 共识评级为 Buy,12 个月平均目标价 $124.00 (较现价 $81.11 上涨空间 52.88%)。
竞争对手与同行
anip competitors股票表现
完整历史关于 ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing co…
what is ani pharmaceuticals, inc. · anip stock overview · ani pharmaceuticals, inc. company profile · who is ani pharmaceuticals, inc. ceo · anip NASDAQ · ani pharmaceuticals, inc. headquarters · ani pharmaceuticals, inc. business segments
关于股票概览与关键数据
ANI Pharmaceuticals, Inc.(ANIP)是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司,于 May 5, 2000 在 NASDAQ 上市。截至最近交易日,ANIP 股价为 $81.11,市值约为 $1.8B。过去12个月累计回报 +28.38%,年初至今回报 +2.75%。
根据 10 位华尔街分析师,ANI Pharmaceuticals, Inc. 股票共识评级为Buy,12个月平均目标价为 $124.00。2025 财年 ANI Pharmaceuticals, Inc. 营收 $883.4M,净利润 $78.3M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。
常见问题
截至最近一个交易日,ANI Pharmaceuticals, Inc.(ANIP)股价为 $81.11,在 NASDAQ 上市,52周区间为 $59.61 – $99.50。